X hits on this document

Word document

ПРОТОКОЛ ВЕДЕНИЯ БОЛЬНЫХ - page 220 / 220

1141 views

0 shares

0 downloads

0 comments

220 / 220

66.

Olanow C, Watts R, Koller W. An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines. Neurology 2001;56(suppl 5):S1–88.

67.

Parkinson Study Group: Safety and efficacy of pramipexole in early Parkinson disease: A randomized dose-ranging study. JAMA 278:125, 1997

68.

Ramaker C, van Hilten J. Bromocriptine versus levodopa in early Parkinson's disease. The Cochrane Library. Oxford: Update Software, 2000.

69.

Rascol O, Brooks D, Korczyn A, et al. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. N Engl J Med 2000;342:1484–91.

70.

Rascol O., Goetz C., Koller W. et al. Treatment interventions for Parkinson’s disease: an evidence based assessment.//Lancet, 2002. – V.359. –P.1589-1598.

71.

Richard I.H. Depression in Parkinson’s disease.// Current Treatment Options in Neurology, 2000. – V.2. –P.263-273.

72.

Riley D.E. Secondary Parkinsonism //In:  J.Jankovic, E.Tolosa (eds). Parkinson's disease and movement disorders. 3nd ed. – Baltimore. Williams&Wilkins, 1998. -P.317-339.

73.

Schumacher JM, Ellias SA, Palmer EP, et al: Transplantation of embryonic porcine mesencephalic tissue in patients with PD. Neurology 54:1042, 2000

74.

Schrag A, Ben-Shlomo Y, Brown R, et al. Young-onset Parkinson's disease revisited--clinical features, natural history, and mortality.// Mov. Disord.,1998.-V.13.-P.885-894.

75.

Schrag A., Ben-Solomo Y., Quinn N.P. Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study//Lancet, 1999. -V.354. -P.1771-1775.

76.

Stacy M., Jankovic J. Differential diagnosis of Parkinson’s disease and parkinsonism-plus syndromes // Neurol.Clin., 1992.-V.10. -P.341-359.

77.

Starkstein S.E., Merello M. Psychiatric and cognitive disorders in Parkinson’s disease. Cambridge Universitu Press, 2002. -229 P.

78.

Waters  C.H. Diagnosis and management of Parkinson’s disease. 1999 –240P.

79.

Wenning G.K., Ben-Solomo Y., Hughes A. et al. What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson’s disease?// J. Neurol. Neurosurg. Psychiatry, 2000. -V.68. -P. 434-440.

80.

Zesiewicz T., Baker M.J., Wahba M. et al, Autonomic nervous system dysfunction in Parkinson’s disease.//Current Treatment Options in Neurology, 2003. – V.5. – P.149-160.

Document info
Document views1141
Page views1141
Page last viewedWed Dec 07 08:41:04 UTC 2016
Pages220
Paragraphs3090
Words41635

Comments